Detalhe da pesquisa
1.
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Lancet
; 393(10183): 1819-1830, 2019 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30955977
2.
Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study.
Support Care Cancer
; 25(2): 459-464, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27714530
3.
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial.
Lancet Oncol
; 17(6): 791-800, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27179402
4.
Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial.
Lancet Oncol
; 16(5): 550-60, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25882987
5.
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial.
Lancet Oncol
; 14(8): 777-86, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23782814
6.
Predictive value of Ki67 for adjuvant chemotherapy in node-negative, hormone receptor-positive breast cancer.
J Med Assoc Thai
; 96 Suppl 2: S60-6, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23590023
7.
A phase II study of the combination of gemcitabine plus carboplatin as the neoadjuvant treatment in locally advanced breast cancer.
J Med Assoc Thai
; 96 Suppl 2: S67-74, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23590024
8.
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.
Lancet Oncol
; 13(1): 25-32, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22153890
9.
Cost-Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: Real-World Evidence after Policy Implementation in Thailand.
Cancers (Basel)
; 15(20)2023 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37894297
10.
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study.
J Clin Oncol
; 41(11): 1986-1991, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36306479
11.
Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice.
Support Care Cancer
; 20(4): 849-55, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21505898
12.
C-reactive protein as a monitor of chemotherapy response in advanced non-small cell lung cancer (CML study).
J Med Assoc Thai
; 95 Suppl 2: S199-207, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22574550
13.
Autoantibody profiles and clinical association in Thai patients with autoimmune retinopathy.
Sci Rep
; 11(1): 15047, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34294798
14.
Cancer anemia survey in Division of Medical Oncology at Siriraj Hospital (CAS).
J Med Assoc Thai
; 92 Suppl 2: S110-8, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19562994
15.
Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study.
Breast Cancer (Dove Med Press)
; 11: 43-51, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30666153
16.
Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP).
Clin Colorectal Cancer
; 18(3): 183-191.e3, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31221542
17.
Real-life clinical pattern, management, and survival in Thai patients with early-stage or metastatic triple-negative breast cancer.
PLoS One
; 13(12): e0209040, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30566471
18.
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical Trial.
JAMA Oncol
; 4(7): 977-984, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29566104
19.
Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies.
Lung Cancer
; 126: 1-8, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30527172
20.
Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study.
Clin Colorectal Cancer
; 16(2): e73-e88, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27780749